相关实验视频
Updated: Jan 16, 2026

07:42
A Data-Driven Approach to Quantifying Immune States in Sepsis
Published on: February 7, 2025
476
解码败血症:解开针对性治疗的关键信号通路
Lingxuan Tang1,2, Wangzheqi Zhang1,3, Yan Liao1,3
1Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai 200433, China.
Research (Washington, D.C.)
|October 3, 2025
概括
败血症涉及复杂的免疫信号通路. 针对这些途径,以及新陈代谢,提供了个性化,多目标的方法来减少炎症和预防器官衰竭,改善患者的治疗结果.
科学领域:
- 免疫学和分子生物学
- 关键护理医学 关键护理医学
背景情况:
- 败血症是一种危及生命的疾病,其特点是免疫反应失调,全身炎症和器官功能障碍.
- 由于败血症的复杂性,目前的抗生素和早期治疗等治疗方法的有效性有限.
研究的目的:
- 审查参与败血症发病的主要信号通路.
- 探索线粒体功能障碍和代谢重编程在败血症中的作用.
- 讨论多目标,个性化治疗策略的潜力.
主要方法:
- 对关键信号通路的审查,包括NF-κB,JAK/STAT,TLRs,MAPK,HIF-1α和Nrf2/Keap1.1.
- 分析线粒体功能障碍和代谢变化的贡献.
- 讨论临床翻译和个性化治疗方法.
主要成果:
- 这些信号通路是免疫激活,炎症和免疫细胞代谢的关键调节者.
- 线粒体功能障碍和代谢重编程显著影响败血症的发展和免疫细胞的功能.
- 选择性抑制特定途径在减少高炎症和预防器官衰竭方面显示出有前途.
结论:
- 未来的研究应该专注于将信号通路洞察力转化为临床应用.
- 需要个性化,多目标的治疗策略来解决败血症的复杂性和变异性.
- 实时监测和治疗的动态调整可以优化干预点并改善败血症预后.
相关概念视频
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Gene Regulation in Microbial Communities: Quorum Sensing
518
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
518
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Amplifying Signals via Enzymatic Cascade
17.3K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
17.3K
The JAK-STAT Signaling Pathway
12.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.0K

